Asia-Pacific Biosimilars Market Report 2018

January 2018 | 108 pages | ID: A9588B6A218EN
QYResearch

Abstracts

In this report, the Asia-Pacific Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Biosimilars for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Biosimilars market competition by top manufacturers/players, with Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Sandoz International GmbH
• Teva Pharmaceuticals Industries
• Amgen Inc
• Biocon
• Dr. Reddy’s Laboratories
• F. Hoffmann-La Roche
• Celltrion
• Samsung Bioepis

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
• Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
• Peptides (Glucagon, Calcitonin)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oncology
• Blood Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Biosimilars Market Report 2017

1 BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars by Product Category
  1.2.1 Asia-Pacific Biosimilars Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
  1.2.4 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
  1.2.5 Peptides (Glucagon, Calcitonin)
1.3 Asia-Pacific Biosimilars Market by Application/End Users
  1.3.1 Asia-Pacific Biosimilars Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Oncology
  1.3.3 Blood Disorders
1.4 Asia-Pacific Biosimilars Market by Region
  1.4.1 Asia-Pacific Biosimilars Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Biosimilars (2012-2022)
  1.5.1 Asia-Pacific Biosimilars Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Biosimilars Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC BIOSIMILARS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Biosimilars Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Biosimilars Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Biosimilars Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Biosimilars (Volume and Value) by Type
  2.2.1 Asia-Pacific Biosimilars Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Biosimilars Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Biosimilars (Volume) by Application
2.4 Asia-Pacific Biosimilars (Volume and Value) by Region
  2.4.1 Asia-Pacific Biosimilars Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Biosimilars Revenue and Market Share by Region (2012-2017)

3 CHINA BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 China Biosimilars Sales and Value (2012-2017)
  3.1.1 China Biosimilars Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Biosimilars Revenue and Growth Rate (2012-2017)
  3.1.3 China Biosimilars Sales Price Trend (2012-2017)
3.2 China Biosimilars Sales Volume and Market Share by Type
3.3 China Biosimilars Sales Volume and Market Share by Application

4 JAPAN BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Biosimilars Sales and Value (2012-2017)
  4.1.1 Japan Biosimilars Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Biosimilars Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Biosimilars Sales Price Trend (2012-2017)
4.2 Japan Biosimilars Sales Volume and Market Share by Type
4.3 Japan Biosimilars Sales Volume and Market Share by Application

5 SOUTH KOREA BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Biosimilars Sales and Value (2012-2017)
  5.1.1 South Korea Biosimilars Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Biosimilars Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Biosimilars Sales Price Trend (2012-2017)
5.2 South Korea Biosimilars Sales Volume and Market Share by Type
5.3 South Korea Biosimilars Sales Volume and Market Share by Application

6 TAIWAN BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Biosimilars Sales and Value (2012-2017)
  6.1.1 Taiwan Biosimilars Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Biosimilars Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Biosimilars Sales Price Trend (2012-2017)
6.2 Taiwan Biosimilars Sales Volume and Market Share by Type
6.3 Taiwan Biosimilars Sales Volume and Market Share by Application

7 INDIA BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 India Biosimilars Sales and Value (2012-2017)
  7.1.1 India Biosimilars Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Biosimilars Revenue and Growth Rate (2012-2017)
  7.1.3 India Biosimilars Sales Price Trend (2012-2017)
7.2 India Biosimilars Sales Volume and Market Share by Type
7.3 India Biosimilars Sales Volume and Market Share by Application

8 SOUTHEAST ASIA BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Biosimilars Sales and Value (2012-2017)
  8.1.1 Southeast Asia Biosimilars Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Biosimilars Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Biosimilars Sales Price Trend (2012-2017)
8.2 Southeast Asia Biosimilars Sales Volume and Market Share by Type
8.3 Southeast Asia Biosimilars Sales Volume and Market Share by Application

9 AUSTRALIA BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Biosimilars Sales and Value (2012-2017)
  9.1.1 Australia Biosimilars Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Biosimilars Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Biosimilars Sales Price Trend (2012-2017)
9.2 Australia Biosimilars Sales Volume and Market Share by Type
9.3 Australia Biosimilars Sales Volume and Market Share by Application

10 ASIA-PACIFIC BIOSIMILARS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Biosimilars Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Sandoz International GmbH
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Biosimilars Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Sandoz International GmbH Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Teva Pharmaceuticals Industries
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Biosimilars Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Teva Pharmaceuticals Industries Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Amgen Inc
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Biosimilars Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Amgen Inc Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Biocon
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Biosimilars Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Dr. Reddy’s Laboratories
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Biosimilars Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Dr. Reddy’s Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 F. Hoffmann-La Roche
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Biosimilars Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 F. Hoffmann-La Roche Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Celltrion
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Biosimilars Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Samsung Bioepis
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Biosimilars Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Samsung Bioepis Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview

11 BIOSIMILARS MANUFACTURING COST ANALYSIS

11.1 Biosimilars Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biosimilars

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC BIOSIMILARS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Biosimilars Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Biosimilars Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Biosimilars Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Biosimilars Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Biosimilars Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Biosimilars Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Biosimilars Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Biosimilars Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Biosimilars Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Biosimilars Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Biosimilars Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilars
Figure Asia-Pacific Biosimilars Sales Volume (K MT) by Type (2012-2022)
Figure Asia-Pacific Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Figure Peptides (Glucagon, Calcitonin) Product Picture
Figure Asia-Pacific Biosimilars Sales (K MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Biosimilars by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Blood Disorders Examples
Table Key Downstream Customer in Blood Disorders
Figure Asia-Pacific Biosimilars Market Size (Million USD) by Region (2012-2022)
Figure China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Biosimilars Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Biosimilars Market Major Players Product Sales Volume (K MT)(2012-2017)
Table Asia-Pacific Biosimilars Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Biosimilars Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Biosimilars Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Biosimilars Sales Share by Players/Suppliers
Figure Asia-Pacific Biosimilars Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Biosimilars Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Biosimilars Revenue Share by Players
Figure 2017 Asia-Pacific Biosimilars Revenue Share by Players
Table Asia-Pacific Biosimilars Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilars by Type (2012-2017)
Figure Asia-Pacific Biosimilars Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilars by Type (2012-2017)
Figure Asia-Pacific Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Biosimilars Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilars by Region (2012-2017)
Figure Asia-Pacific Biosimilars Sales Market Share by Region in 2016
Table Asia-Pacific Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Biosimilars Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biosimilars by Region (2012-2017)
Figure Asia-Pacific Biosimilars Revenue Market Share by Region in 2016
Table Asia-Pacific Biosimilars Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Biosimilars Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Biosimilars Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Biosimilars Sales Market Share by Application (2012-2017)
Figure China Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure China Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table China Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table China Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure China Biosimilars Sales Volume Market Share by Type in 2016
Table China Biosimilars Sales Volume (K MT) by Applications (2012-2017)
Table China Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure China Biosimilars Sales Volume Market Share by Application in 2016
Figure Japan Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table Japan Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table Japan Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Japan Biosimilars Sales Volume Market Share by Type in 2016
Table Japan Biosimilars Sales Volume (K MT) by Applications (2012-2017)
Table Japan Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Japan Biosimilars Sales Volume Market Share by Application in 2016
Figure South Korea Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure South Korea Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table South Korea Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table South Korea Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure South Korea Biosimilars Sales Volume Market Share by Type in 2016
Table South Korea Biosimilars Sales Volume (K MT) by Applications (2012-2017)
Table South Korea Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure South Korea Biosimilars Sales Volume Market Share by Application in 2016
Figure Taiwan Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Taiwan Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table Taiwan Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table Taiwan Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Biosimilars Sales Volume Market Share by Type in 2016
Table Taiwan Biosimilars Sales Volume (K MT) by Applications (2012-2017)
Table Taiwan Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Biosimilars Sales Volume Market Share by Application in 2016
Figure India Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure India Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table India Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table India Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure India Biosimilars Sales Volume Market Share by Type in 2016
Table India Biosimilars Sales Volume (K MT) by Application (2012-2017)
Table India Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure India Biosimilars Sales Volume Market Share by Application in 2016
Figure Southeast Asia Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Biosimilars Sales Volume Market Share by Type in 2016
Table Southeast Asia Biosimilars Sales Volume (K MT) by Applications (2012-2017)
Table Southeast Asia Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Biosimilars Sales Volume Market Share by Application in 2016
Figure Australia Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Australia Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table Australia Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table Australia Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Australia Biosimilars Sales Volume Market Share by Type in 2016
Table Australia Biosimilars Sales Volume (K MT) by Applications (2012-2017)
Table Australia Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Australia Biosimilars Sales Volume Market Share by Application in 2016
Table Pfizer Biosimilars Basic Information List
Table Pfizer Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Sandoz International GmbH Biosimilars Basic Information List
Table Sandoz International GmbH Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sandoz International GmbH Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Sandoz International GmbH Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Sandoz International GmbH Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Teva Pharmaceuticals Industries Biosimilars Basic Information List
Table Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Industries Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Industries Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Teva Pharmaceuticals Industries Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Inc Biosimilars Basic Information List
Table Amgen Inc Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Inc Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Amgen Inc Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Inc Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Biocon Biosimilars Basic Information List
Table Biocon Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biocon Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Biocon Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Biocon Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Dr. Reddy’s Laboratories Biosimilars Basic Information List
Table Dr. Reddy’s Laboratories Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dr. Reddy’s Laboratories Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Dr. Reddy’s Laboratories Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Dr. Reddy’s Laboratories Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table F. Hoffmann-La Roche Biosimilars Basic Information List
Table F. Hoffmann-La Roche Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure F. Hoffmann-La Roche Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Celltrion Biosimilars Basic Information List
Table Celltrion Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celltrion Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Celltrion Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Celltrion Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Samsung Bioepis Biosimilars Basic Information List
Table Samsung Bioepis Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Samsung Bioepis Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Samsung Bioepis Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Samsung Bioepis Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/MT) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Manufacturers in 2016
Table Major Buyers of Biosimilars
Table Distributors/Traders List
Figure Asia-Pacific Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Biosimilars Price (USD/MT) and Trend Forecast (2017-2022)
Table Asia-Pacific Biosimilars Sales Volume (K MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Biosimilars Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Biosimilars Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Biosimilars Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Biosimilars Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Biosimilars Revenue Market Share Forecast by Region in 2022
Figure China Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure China Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure India Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Australia Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Biosimilars Sales (K MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Biosimilars Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Biosimilars Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Biosimilars Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Biosimilars Price (USD/MT) Forecast by Type (2017-2022)
Table Asia-Pacific Biosimilars Sales (K MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources